REDHILL BIOPHARMA LTD. Cash Flows From Used In Financing Activities
REDHILL BIOPHARMA LTD. (RDHL) reported Cash Flows From Used In Financing Activities of $3.26 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2025-09-05
- REDHILL BIOPHARMA LTD. cash flows from used in financing activities for the quarter ending 2022-06-30 was $14.92M.
- REDHILL BIOPHARMA LTD. cash flows from used in financing activities for the quarter ending 2021-06-30 was -$1.77M, a 132.41% decline year-over-year.
- REDHILL BIOPHARMA LTD. cash flows from used in financing activities for the quarter ending 2020-06-30 was $5.46M.
- REDHILL BIOPHARMA LTD. cash flows from used in financing activities for the quarter ending 2019-06-30 was -$199.00K.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 6 month as first filed | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|---|---|
| 2025-06-30 | $3.26M 6-K · filed 2025-09-05 | |||
| 2024-12-31 | $8.42M 20-F · filed 2025-04-10 | |||
| 2024-06-30 | $7.90M 6-K · filed 2025-09-05 | |||
| 2023-12-31 | $21.44M 20-F · filed 2025-04-10 | |||
| 2023-06-30 | $4.81M 6-K · filed 2024-08-29 | |||
| 2022-12-31 | $11.45M 20-F · filed 2025-04-10 | |||
| 2022-06-30 | $14.92M 6-K · filed 2022-11-07 | $9.97M 6-K · filed 2023-08-17 | ||
| 2021-12-31 | $73.46M 20-F · filed 2024-04-08 | |||
| 2021-06-30 | -$1.77M 6-K · filed 2022-11-07 | $56.89M 6-K · filed 2022-11-07 | ||
| 2020-12-31 | $84.37M 20-F · filed 2023-04-28 | |||
| 2020-06-30 | $5.46M 6-K · filed 2021-08-26 | $64.47M 6-K · filed 2021-08-26 | ||
| 2019-12-31 | $35.51M 20-F · filed 2022-03-17 | |||
| 2019-06-30 | -$199.00K 6-K · filed 2020-08-13 | -$385.00K 6-K · filed 2020-08-13 | ||
| 2018-12-31 | $41.76M 20-F · filed 2021-03-18 | |||
| 2018-06-30 | -$145.00K 6-K · filed 2019-07-23 | $355.00K 6-K · filed 2018-08-30 | ||
| 2017-12-31 | $25.65M 20-F · filed 2020-03-04 | |||
| 2017-06-30 | $175.00K 6-K · filed 2018-08-30 | $4.69M 6-K · filed 2018-08-30 | ||
| 2016-12-31 | $36.02M 20-F · filed 2019-02-26 | |||
| 2015-12-31 | $54.79M 20-F · filed 2018-02-22 |